PainChek Stock Forecast, Price & News

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

Receive PCK News and Ratings via Email

Sign-up to receive the latest news and ratings for PainChek and its competitors with MarketBeat's FREE daily newsletter.

About PainChek

PainChek Limited develops and commercializes mobile medical device applications that provides pain assessment for individuals primarily in Australia and Europe. The company offers PainChek, which uses camera in smartphone and tablets to capture video that is analyzed in real time using facial recognition software to indicate the presence of the pain. It serves patients suffering with dementia. The company was formerly known as ePAT Technologies Ltd and changed its name to PainChek Limited. in January 2018. PainChek Limited is based in Sydney, Australia.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

PainChek (ASX:PCK) Frequently Asked Questions

What stocks does MarketBeat like better than PainChek?

Wall Street analysts have given PainChek a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but PainChek wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are PainChek's key executives?

PainChek's management team includes the following people:
  • Mr. Philip Daffas B.Sc., M.B.A., BSc, Dip EENG, MBA, GAICD, MD, CEO & Director
  • Mr. Iain McAdam, Chief Financial Officer
  • Mr. Andrew Hoggan, Head of Operations
  • Mr. Scott Robertson M.B.A., Chief Technology Officer
  • Prof. Jeff Hughes Ph.D., Chief Scientific Officer
  • Mr. David Allsopp, Head of Bus. Devel. ANZ
  • Mr. Pete Shergill, Head of Bus. Devel. UK
  • Ms. Sally McDow, Company Sec.

Who are some of PainChek's key competitors?

What is PainChek's stock symbol?

PainChek trades on the ASX under the ticker symbol "PCK."

How much money does PainChek make?

PainChek has a market capitalization of $0.00 and generates $240,424.00 in revenue each year.

What is PainChek's official website?

The official website for PainChek is

How can I contact PainChek?

The company can be reached via phone at 1800 098 809.

This page was last updated on 7/30/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.